Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting, the Eye Care Network spoke with Peter Stalmans, MD, PhD, ...
Two first-in-class molecules from EyeBio have shown promising results for the treatment of retinal diseases, according to a presenter at [email protected] (MK-3000) is an antibody that ...
Serum selenium and redox biomarkers show potential to aid in the diagnosis and prognosis of retinal vein occlusion.